Who are ethinyl estradiol and cyproterone acetate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): fenofibrate and tibolone, Add back therapy 1 (tibolone), Tibolone plus Xiangshao granules, Tibolone (Livial), Black Cohosh (iCR) or tibolone, Ethinyl Estradiol + Cyproterone acetate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ethinyl-estradiol-and-cyproterone-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

ethinyl estradiol and cyproterone acetate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ethinyl estradiol and cyproterone acetate (ethinyl estradiol and cyproterone acetate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combined oral contraceptive with anti-androgenic activity. Area: Contraception and Gynecology.

marketed Combined oral contraceptive with anti-androgenic activity Estrogen receptor, progesterone receptor, androgen receptor Contraception and Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

ethinyl estradiol and cyproterone acetate (ethinyl estradiol and cyproterone acetate) — S.C.B. Medical College and Hospital. Ethinyl estradiol and cyproterone acetate is a combined oral contraceptive that suppresses ovulation through hormonal inhibition and reduces androgenic effects through anti-androgenic activity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
ethinyl estradiol and cyproterone acetate TARGET	ethinyl estradiol and cyproterone acetate	S.C.B. Medical College and Hospital	marketed	Combined oral contraceptive with anti-androgenic activity	Estrogen receptor, progesterone receptor, androgen receptor
fenofibrate and tibolone	fenofibrate and tibolone	Keogh Institute for Medical Research	marketed	Fibrate + Selective Estrogen Receptor Modulator (SERM)	PPAR-α (fenofibrate); Estrogen receptor, progesterone receptor, androgen receptor (tibolone)
Add back therapy 1 (tibolone)	Add back therapy 1 (tibolone)	University of Cagliari	marketed	Selective Tissue Estrogenic Activity Regulator (STEAR); Hormone Replacement Therapy	Estrogen receptor, Progesterone receptor, Androgen receptor
Tibolone plus Xiangshao granules	Tibolone plus Xiangshao granules	Peking Union Medical College Hospital	marketed	Hormone replacement therapy (HRT) / Selective tissue estrogenic activity regulator (STEAR)	Estrogen receptor, Progesterone receptor, Androgen receptor
Tibolone (Livial)	Tibolone (Livial)	Wyeth is now a wholly owned subsidiary of Pfizer	marketed	Selective tissue estrogenic activity regulator (STEAR); synthetic steroid	Estrogen receptor, progesterone receptor, androgen receptor
Black Cohosh (iCR) or tibolone	Black Cohosh (iCR) or tibolone	Schaper & Bruemmer GmbH & Co KG	phase 3	Herbal extract / Selective tissue estrogenic activity regulator (STEAR)	Serotonin receptors (Black Cohosh); estrogen receptor, progesterone receptor, androgen receptor (tibolone)
Ethinyl Estradiol + Cyproterone acetate	Ethinyl Estradiol + Cyproterone acetate	Fundação Educacional Serra dos Órgãos	marketed	Combined oral contraceptive with anti-androgenic activity	Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combined oral contraceptive with anti-androgenic activity class)

Fundação Educacional Serra dos Órgãos · 1 drug in this class
S.C.B. Medical College and Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ethinyl estradiol and cyproterone acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-and-cyproterone-acetate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab